Search

Christy Jurgens Phones & Addresses

  • Colchester, CT
  • Stonington, CT
  • 5212 Pony Hill Ct, Lincoln, NE 68516 (531) 289-6553
  • Omaha, NE
  • Rahway, NJ
  • Brooklyn, NY
  • Somerset, NJ
  • Durham, NC
  • Laurel, MD
  • Chapel Hill, NC

Work

Company: Suny downstate medical center Apr 2008 to Oct 2012 Position: Research assistant professor, graduate program in molecular and cellular biology

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Florida 2002

Skills

Virology • Molecular Biology • Assay Development • Immunology • Cell Culture • Vaccines • In Vivo • Biotechnology • Infectious Diseases • Biochemistry • Viral Vectors • Cell Biology • Genetics • In Vitro • Elisa • Animal Models • Translational Research • Tissue Culture • Protein Expression • Immunoassays • Transfection • Dna • Western Blotting • Clinical Development • Antibodies • Genomics • Life Sciences • Innate Immunity • Lifesciences • Rna Isolation • Processes Development

Ranks

Certificate: Project Leadership

Industries

Pharmaceuticals

Resumes

Resumes

Christy Jurgens Photo 1

Regional Manager

Location:
56 Wolcott Ave, Stonington, CT 06378
Industry:
Pharmaceuticals
Work:
Suny Downstate Medical Center Apr 2008 - Oct 2012
Research Assistant Professor, Graduate Program In Molecular and Cellular Biology

International Aids Vaccine Initiative (Iavi) Apr 2008 - Oct 2012
Principal Scientist

Global Vaccines, Inc. 2007 - 2008
Staff Scientist

University of North Carolina at Chapel Hill 2002 - 2007
Post Doctoral Research Associate

University of Florida Jan 1998 - Jan 2002
Graduate Research Assistant
Education:
University of Florida 2002
Doctorates, Doctor of Philosophy
University of Florida College of Medicine 1997 - 2002
Doctorates, Doctor of Philosophy, Microbiology, Immunology
The University of Georgia 1994 - 1996
Bachelors, Bachelor of Science, Genetics
University of Georgia
Millard North High School
Skills:
Virology
Molecular Biology
Assay Development
Immunology
Cell Culture
Vaccines
In Vivo
Biotechnology
Infectious Diseases
Biochemistry
Viral Vectors
Cell Biology
Genetics
In Vitro
Elisa
Animal Models
Translational Research
Tissue Culture
Protein Expression
Immunoassays
Transfection
Dna
Western Blotting
Clinical Development
Antibodies
Genomics
Life Sciences
Innate Immunity
Lifesciences
Rna Isolation
Processes Development
Certifications:
Project Leadership

Business Records

Name / Title
Company / Classification
Phones & Addresses
Christy Jurgens
Phd Associate Member
University of North Carolina At Chapel Hill
Colleges, Universities, and Professional Scho...
7240 Wing D Cb, Chapel Hill, NC 27599
Christy Jurgens
Phd Associate Member
University of North Carolina At Chapel Hill
Colleges, Universities, and Professional Scho...
7240 Wing D Cb, Chapel Hill, NC 27599

Publications

Us Patents

Chimeric Virus Vaccines

US Patent:
20120121650, May 17, 2012
Filed:
Aug 16, 2007
Appl. No.:
12/377927
Inventors:
Robert E. Johnston - Chapel Hill NC, US
Christy Jurgens - Rahway NJ, US
Kelly Young Poe - Durham NC, US
International Classification:
A61K 31/7088
C12N 15/86
A61P 37/02
C12N 7/01
US Classification:
4242781, 4352351, 4353201
Abstract:
The present invention provides novel self-replicating and self-propagating chimeric viral vectors and chimeric virus particles comprising a modified genome of a carrier RNA virus packaged within structural proteins of a second virus. Also provided are pharmaceutical formulations comprising the chimeric viral vectors and virus particles and methods of inducing an immune response by administration of the chimeric viral vectors and virus particles or nucleic acids (e.g., DNA and/or RNA) encoding the same to the subject.

Novel Vesicular Stomatitis Virus And Virus Rescue System

US Patent:
20130095556, Apr 18, 2013
Filed:
Sep 20, 2012
Appl. No.:
13/623437
Inventors:
International AIDS Vaccine Initiative - New York NY, US
Maoli Yuan - Brooklyn NY, US
Kevin Wright - Brooklyn NY, US
Christy Jurgens - Rahway NJ, US
Assignee:
International AIDS Vaccine Initiative - New York NY
International Classification:
C12N 7/00
US Classification:
4352351
Abstract:
The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines as well as the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.

Immunoselection Of Recombinant Vesicular Stomatitis Virus Expressing Hiv-1 Proteins By Broadly Neutralizing Antibodies

US Patent:
20130189754, Jul 25, 2013
Filed:
Sep 12, 2012
Appl. No.:
13/612001
Inventors:
Christopher L. Parks - Boonton NJ, US
Christy Jurgens - Rahway NJ, US
Perry J. Tiberio - New York NY, US
Simon Hoffenberg - Hartsdale NY, US
Assignee:
INTERNATIONAL AIDS VACCINE INITIATIVE - New York NY
International Classification:
A61K 35/76
US Classification:
4351739, 4353201
Abstract:
The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of AIDS. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.

Methods To Improve Vector Expression And Genetic Stability

US Patent:
20130266989, Oct 10, 2013
Filed:
Mar 10, 2013
Appl. No.:
13/792103
Inventors:
Christopher L. Parks - Boonton NJ, US
Kevin J. Wright - Brooklyn NY, US
Maoli Yuan - Brooklyn NY, US
Christy K. Jurgens - Rahway NJ, US
Xinsheng Zhang - Merrick NY, US
Arban Domi - Parsippany NJ, US
Simon Hoffenberg - Hartsdale NY, US
Maria J. Chiuchiolo - Brooklyn NY, US
Svetlana Rabinovich - Staten Island NY, US
Aaron J. Wilson - Brooklyn NY, US
Ivo C. Lorenz - Brooklyn NY, US
Assignee:
International AIDS Vaccine Initiative - New York NY
International Classification:
C12N 15/68
US Classification:
435 9141
Abstract:
The present invention relates to methods of developing gene inserts that are more compatible with the host vectors by modifying a protein sequence to lessen potential interference with vector propagation while ensuring that the protein is expressed and processed efficiently and maintains desired structural features, and designing a gene with a nucleotide sequence that resembles the base composition of the host vector genome.

Novel Vesicular Stomatitis Virus And Virus Rescue System

US Patent:
20200172932, Jun 4, 2020
Filed:
Dec 17, 2019
Appl. No.:
16/717360
Inventors:
- New York NY, US
Maoli Yuan - Brooklyn NY, US
Kevin Wright - Brooklyn NY, US
Christy Jurgens - Rahway NJ, US
International Classification:
C12N 15/86
C12N 7/00
Abstract:
The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines as well as the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.

Novel Vesicular Stomatitis Virus And Virus Rescue System

US Patent:
20170198305, Jul 13, 2017
Filed:
Jan 27, 2017
Appl. No.:
15/417256
Inventors:
- New York NY, US
Maoli Yuan - Brooklyn NY, US
Kevin Wright - Brooklyn NY, US
Christy Jurgens - Rahway NJ, US
International Classification:
C12N 15/86
C12N 7/00
Abstract:
The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines as well as the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.

Methods To Improve Vector Expression And Genetic Stability

US Patent:
20160222392, Aug 4, 2016
Filed:
Apr 20, 2016
Appl. No.:
15/133260
Inventors:
- New York NY, US
Kevin J. Wright - Brooklyn NY, US
Maoli Yuan - Brooklyn NY, US
Christy K. Jurgens - Rahway NJ, US
Xinsheng Zhang - Merrick NY, US
Arban Domi - Parsippany NJ, US
Simon Hoffenberg - Hartsdale NY, US
Maria J. Chiuchiolo - Brooklyn NY, US
Svetlana Rabinovich - Staten Island NY, US
Aaron J. Wilson - Brooklyn NY, US
Ivo C. Lorenz - Brooklyn NY, US
International Classification:
C12N 15/68
C12N 15/86
C12N 7/00
Abstract:
The present invention relates to methods of developing gene inserts that are more compatible with the host vectors by modifying a protein sequence to lessen potential interference with vector propagation while ensuring that the protein is expressed and processed efficiently and maintains desired structural features, and designing a gene with a nucleotide sequence that resembles the base composition of the host vector genome.
Christy K Jurgens from Colchester, CT, age ~54 Get Report